Both decreased autophagy positive regulator AMP activated protein kinase (AMPK) level and promoted mitophagy are observed in oxygen-glucose deprivation (OGD) cardiomyocytes treated with pigment epithelium-derived factor (PEDF). This contradictory phenomenon and its underlying mechanisms have not been thoroughly elucidated. Our previous study reveals that PEDF increases the protein kinase Cα (PKCα) and phospho-PKCα (p-PKCα) contents to promote mitophagy. Thus, we investigated the association between PKCα and mitophagy. Here we identify an interaction between PKCα and Unc-51-like kinase 1 (ULK1), essential component of mitophagy.
oxidative stress and DNA damage. 5 AMP activated protein kinase (AMPK) is a heterotrimeric complex consisting of α-, β-and γ-subunits that responds to energetic stress to maintain energy balance through phosphorylation of a diverse network of key metabolic pathways. 6 Recently, AMP activated protein kinase (AMPK) has been reported as an activator of mitophagy that occurs through pleiotropic mechanism involving inhibition of the mammalian target of rapamycin (mTOR) complex and direct phosphorylation and activation of Unc-51-like kinase 1 (ULK1). Specifically, AMPK inhibits mTOR through phosphorylation of Raptor to induce14-3-3τ binding to Raptor. 7 In addition, AMPK directly activates mitophagy through phosphorylation of ULK1 at several primary sites, while mTOR inhibits this process via ULK1 phosphorylation at Ser757. 8 Pigment epithelium-derived factor (PEDF) has gained attention as an endogenous secretory multifunctional protein, which is commonly expressed in various tissues 9 and implicated in many cardiovascular diseases. 10 Our pervious study indicated that PEDF expression is markedly decreased in oxygen-glucose deprivation (OGD) cardiomyocytes and exogenous PEDF mediates the degradation of AMPK via an ubiquitin-proteasome pathway. 11 However, another study reveals that PEDF, surprisingly, promotes cardiomyocyte mitophagy via protein kinase Cα (PKCα)-ULK1-FUNDC1 pathway during OGD. 12 These findings indicated that during OGD, PEDF-induced ULK1 activation and mitophagy is probably dependent on PKCα rather than AMPK. It is noteworthy that the PKC family functions many signal transduction downstream, 13 and PKCα is the predominant conventional PKC isoform expressed in mouse, rat and human heart. 14 Furthermore, several studies have also demonstrated that mitophagy is associated with the PKC pathway. 15, 16 Altogether, this inspired us to explore the physical relevance between PKCα and ULK1 in PEDF-treated OGD cardiomyocytes.
In the current study, we investigated the importance of PKCα in controlling mitophagy. We find that during OGD, the substitution of AMPK with PKCα phosphorylates/activates ULK1 and Raptor to promote mitophagy. We also show that the phospho-ULK1 induced by PEDF-PKCα promotes FUNDC1-mediated mitophagy and decrease the release of mitochondrial ROS and DNA, indicating that PEDF cardioprotective regulation of mitophagy is associated with PKCα rather than AMPK.
| MATERIALS AND METHODS
Materials and expanded methods are presented in the Online Data S1.
| Rat neonatal left ventricular cardiomyocyte isolation and culture
Neonatal cardiomyocytes were isolated from newborn Sprague-Dawley (SD) rats. Cardiomyocytes were cultured in Dulbecco's modified Eagle's medium (Gibco) contain 4.5 g/L glucose with 10% foetal bovine serum and cultured at 37°C in a humidified atmosphere containing 5% CO 2 .
Oxygen-glucose deprivation (OGD) was achieved by culturing cells in glucose-free DMEM (Gibco) without FBS supplement for glucose deprivation and in a tri-gas incubator (Heal Force, Shanghai, China) saturated with 1% O 2 /5% CO 2 /94% N 2 at 37°C for oxygen deprivation.
| Cell viability and LDH release assay
Cell viability and LDH release were detected by Cell Counting Kit-8 kit (CCK-8; Dojindo, Tokyo, Japan) and LDH Cytotoxicity Assay Kit (Roche, Basel, Switzerland) according to the manufacturer's instructions.
| Western blot
Protein samples from cardiomyocytes in the different groups were lysed for total protein extraction. Protein concentration was determined using a bicinchoninic acid (BCA) assay according to the manufacturer's protocol. Aliquots of equal amounts of protein from the lysate underwent
Western blot analysis. The same membrane was stripped and reblotted with specific antibodies. For quantitative analysis, the bands were quantified using Image J software (NIH, Bethesda, USA) and the data were transformed and normalized relative to β-actin, other than specifically noted, as the integral optical density (IOD) ratio.
| In vitro kinase assay
ULK1 and Raptor were pre-incubated with p-PKCα in vitro. Cardiomyocytes were subjected to oxygen-glucose deprivation for 
| Co-immunoprecipitation
The whole proteins of cardiomyocytes were extracted using the special lysis buffer for immunoprecipitation. The lysates were centrifuged, and protein concentrations were measured by BCA assay.
Part of the supernatant was used as input control, and the rest was 
| Statistical analysis
Data are expressed as means ± SEM. Data between two groups were compared using two-tailed Student's t test and multiple comparisons utilized one-way ANOVA followed by Student-Newman-Keuls test.
Statistical analysis was performed using PASW Statistic 21 (SPSS Inc., Chicago, USA). P < 0.05 was considered as significant difference.
| RESULTS

| PEDF promotes OGD cardiomyocyte mitophagy via PKCα-ULK1-FUNDC1 pathway
First, we examined the PEDF effects on OGD cardiomyocyte mitophagy. As shown in Figure 1A , p-PKCα, PKCα and ULK1 levels were increased during oxygen-glucose deprivation (OGD) compared with normoxia. PEDF could further significantly increase their content under OGD but not normal conditions. At mitochondria, FUNDC1 is an integral mitochondrial outer-membrane protein. Structurally, FUNDC1 has two essential phosphorylation sites including Tyr18 and Ser13. Phosphorylated FUNDC1 generates steric hindrance for LC3II binding, 17 thus effectively inhibiting mitophagy. 18 Ischaemic or hypoxic stimulus alleviates FUNDC1 phosphorylation at Tyr18, leading to induction of mitophagy in ischaemia. 17 And LC3-I is lipidated to LC3-II and associates to the cargo isolation membrane allowing for autophagosome formation. 19 The expression of LC3-II and phospho- were more red punctum in PEDF-treated OGD group than in normal or OGD control group, which was attenuated by Go6976, SBI-0206965 or siFUNDC1. Mitochondrial autophagy was further detected by colocalization of LC-3 with Mito-tracker Red-stained mitochondria. 20 As shown in Figure S1B , the intensity of LC-3 that co-localized with mitochondria was significantly increased in PEDF-treated OGD group when compared to the normal or OGD control group, which was significantly attenuated by Go6976 or SBI-0206965. Similarly, pre-treated with These results indicate that PEDF increase mitophagy of OGD cardiomyocytes through PEDF-PKCα-ULK1-FUNDC1 axis.
| PKCα interacts with ULK1 directly through the S/T domain
It is well established that AMPKα participates in ULK1-mediated mitophagy, so we determined the expression of AMPKα. Similar to our previous study, phospho-AMPKα (p-AMPKα) was increased during OGD for 4 hours and both p-AMPKα and AMPKα levels were significantly decreased to~50% with the treatment of PEDF compared with OGD control, and Go6876 has no effect on the expressions of AMPKα and p-AMPKα with PEDF ( Figure 2A ) or not ( Figure S2 ) when compared to OGD control group or PEDF-treated OGD group, respectively. These findings reveal that PEDF-promoted mitophagy in OGD cardiomyocytes was probably independent with AMPK. Previous study has reported that AMPK binds to the serine/threonine-rich domain (S/T domain) of ULK1 which is required for ULK1-mediated autophagy. 21 Thus, it is of interest to determine whether PKCα could directly interact with S/T domain of ULK1. As shown in Figure 2B in the presence of PEDF during OGD ( Figure 2D ). Then we generated a deletion mutant ULK1 (Δ654-828) that lacks the AMPK binding domain. Notably, this deletion mutant ULK1 could not bind to PKCα.
Similar results were observed by confocal laser scanning microscope which reinforce the notion that PKCα binding to ULK1 through the S/ T domain with PEDF treatment under OGD conditions ( Figure 2E ).
| PKCα is required for the phosphorylation of
Raptor and ULK1 at Ser317, 555 and 777
Next, we determine whether PKCα could phosphorylate ULK1 and Ser317 and Ser777. 8 Hence, we aimed to verify whether PKCα phosphorylated ULK1 through these sites. As shown in Figure 3B ,
PKCα induces the phosphorylation of Raptor and ULK1 at S317, S555 and S777. A, Cardiomyocytes were treated with PEDF or PEDF+Go6976 and then immunoprecipitated with ULK1 antibody. ULK1, PKCα, p-Raptor, Raptor, mTOR and 14-3-3τ were determined using their antibodies, n = 5. (B) Western bolt for p-ULK1 (Ser317, 555, 777) and ULK1 in cardiomyocytes treated with PEDF or PEDF+Go6976 under normal conditions or before OGD 4 hours, n = 6. *P < 0.05, **P < 0.01 vs relative normal control, # P < 0.05, ## P < 0.01 vs relative OGD control F I G U R E 2 PKCα interacts with the S/T domain of ULK1. A, Protein levels of p-AMPKα, AMPKα in cardiomyocytes treated with PEDF or not under normal conditions or subjected to OGD for 4 hours, n = 6. B, Cardiomyocytes were treated with PEDF, AMPKα inhibitor (Compound C, 10 μmol/L) or AMPKα activator (AICAR, 1 mmol/L), then immunoprecipitated with ULK1 antibody. ULK1, AMPKα, p-AMPKα, PKCα and p-PKCα were determined using their antibodies, n = 4. IP: immunoprecipitation, IB: immunoblotting. C, Representative images showing LC3 staining in different groups of Cardiomyocytes infected with GFP-RFP-LC3 adenovirus for 24 hours, bar = 60 μm. Cardiomyocytes were treated with PEDF, AICAR and Compound C before OGD for 4 hours, n = 30 from three independent experiments. D, Cardiomyocytes were treated with PEDF, lentiviral short hairpin RNA targeting rat ULK1 (shULK1), deletion mutant ULK1 (mULK1 Δ654-828) or empty vehicle, then immunoprecipitated with ULK1 antibody. ULK1, AMPKα, p-AMPKα, PKCα and p-PKCα were determined using their antibodies, n = 4. IP: immunoprecipitation, IB: immunoblotting. E, Confocal immunofluorescence analysis of PKCα interaction with ULK1 in cardiomyocytes, bar = 60 μm. **P < 0.01 vs normal control, ## P < 0.01 vs OGD control impressively, the phosphorylation of ULK1 at Ser555, Ser317 and Ser777 was significantly increased in PEDF-treated OGD cardiomyocytes compared with normal or OGD control. Pre-treated with Go6976 abolished the increase of p-ULK1 by PEDG. These results indicated that both phosphorylation of Raptor and ULK1 and recruitment of 14-3-3τ were related to PEDF-promoted PKCα level.
| The phosphate group of phospho-ULK1 (p-ULK1) and phospho-Raptor (p-Raptor) is from phospho-PKCα
Previous findings indicated that phospho-PKCα (p-PKCα) was also increased in PEDF-treated cardiomyocytes ( Figure 1A) . Therefore, it is of interest to determine whether the phosphate group of p-ULK1
and p-Raptor were transferred from p-PKCα. We labelled 32 
| PEDF steered phospho-ULK1 is important for
FUNDC1-mediated mitophagy
Next, the functional significance of PEDF-induced Ser317, Ser555
and Ser777 phosphorylation in ULK1 activation was examined. PEDF markedly activated wild-type ULK1, but did not activate the phosphorylation defective S317A, S555A and S777A mutant ( Figure 5A ).
The expression of p-FUNDC1 in phosphorylation defective ULK1 mutant groups was significantly increased and decreased compared with PEDF group and PEDF+Go6976 group, respectively. Mitochondrial autophagy was further detected by tandem GFP-RFP-LC3 adenovirus construct. As shown in Figure 5B , there were less red puncta in phosphorylation defective ULK1 mutant groups than PEDF group and pre-treated with Go6976 further reduced the quantitative of the red puncta. Similar results were observed in mitochondrial autophagy detected by co-localization of LC-3 with Mito-tracker Red-stained F I G U R E 4 Phospho-PKCα contributes its phosphate group to phospho-ULK1 and phospho-Raptor. A, Cardiomyocytes were deprived of oxygen and glucose 4 hours as indicated after treated with PEDF and PEDF+Go6976. p-ULK1 and p-Raptor were immunoblotted and phosphorylation was examined by 32 P-autoradiogram.
Proteins were resolved by SDS-PAGE and visualized with autoradiogram (top) and Western blot (WB; bottom), n = 6. B, Schematic representation of PEDFmediated p-PKCα induces the phosphorylation of ULK1 and suppresses the inhibitory effect of mTOR on the ULK1 autophagic complex. *P < 0.05, **P < 0.01 vs normal control, # P < .05, ## P < 0.01 vs OGD control, ΔΔ P < 0.01 vs OGD+PEDF group mitochondria. As shown in Figure S1E , the intensity of LC-3 that colocalized with mitochondria in phosphorylation defective ULK1 mutant groups was markedly increased and decreased compared with PEDF group and PEDF+Go6976 group, respectively. Consistently, phosphorylation defective mutants significantly attenuated PEDF-induced increase in colocalization and fluorescence intensity of the Mito-tracker Red ( Figure S1F and G) . Pre-treated with Go6976 further reduced the colocalization and fluorescence intensity. These findings demonstrated that the phosphorylation of ULK1 at Ser317, 555 and 777 induced by PEDF was all essential for FUNDC1-mediated mitophagy.
| PEDF reduces the release of mitochondrial ROS and DNA into cytosol
Previous studies reveal that the major source of mitochondrial damage comes from imbalanced production of reactive oxygen species (mtROS), and mtROS subsequently impair mitochondrial structure and mitochondrial biogenesis via oxidative modifications on macromolecules, such as mitochondrial DNA (mtDNA). 23, 24 Thus, we next evaluated the levels of mtROS and mtDNA. Phosphorylation defective ULK1 mutant at Ser317, 555 and 777 were all significantly decreased, although not completely, the PEDF- (Figure 6D) . Together, our data demonstrated the importance of Ser317, Ser555 and Ser777 phosphorylation of PEDF-induced and PKCα-dependent ULK1 activation in mitigating mitochondrial damage. [25] [26] [27] [28] [29] and also physical stresses like hypoxia. 30 The kinase activity of PKCα is regulated by phosphorylation of conserved residues in its kinase domain: the activation-loop site Thr497, the autophosphorylation site Thr638 and the hydrophobic C-terminal site Ser657. 31, 32 PKCα exhibits almost no activity without phosphorylation at these sites, and phosphorylation of Ser657 is currently used as an indicator for PKCα activation. 31, 33 In the present study, we first presented a physical relevance between PKCα and ULK1, which phosphorylates ULK1 at Ser317, 555, 777 and Raptor to promote mitophagy in cardiomyocyte treated with PEDF ( Figure 4B ). It is known that AMPK, a classical ULK1-binding partner, binds to amino acids 654-828 within the S/T domain of ULK1. 21 However, in our study, the ischaemic cardiomyocytes As PEDF does not promote cardiomyocyte p-PKCα level and mitophagy under normoxic conditions, oxygen-glucose deprivation may be one of the necessary conditions for PEDF to play a cardioprotective role. But the specific mechanism remains to be further investigation.
Taken together, our data reveal a novel mechanism that PEDFinduced p-PKCα replaces AMPK-ULK1 interaction and phosphorylates ULK1 at Ser 317, 555 and 777 to promote mitophagy. Tactic for targeting of PEDF mitophagy pathways in AMI may be of therapeutic benefit suggesting a new strategy to protect cell viability and fight cardiovascular diseases.
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Zhongming Zhang http://orcid.org/0000-0001-9435-8000 F I G U R E 6 The release of mitochondrial ROS and DNA in cytosol is decreased by PEDF-induced phospho-ULK1. A and B, Fluorescence microscope of (A) Mito-SOX Red-labelled ROS production and release in cytosol and quantification of (B) fluorescence density, bar = 100 μm, n = 30 from 3 independent experiments. Cardiomyocytes were treated with PEDF or PEDF+Go6976 under normal conditions or before OGD 4 hours. S317/555/777A mutants were transfected into cardiomyocytes as indicated. C, Cytosolic mitochondrial DNA copy number was measured by quantitative PCR, n = 7. Wild type or S317/555/777A mutational cardiomyocytes were treated with PEDF or Go6976 under normal conditions or before OGD 4 hours. D, Quantification of mitochondrial superoxide was detected with flow cytometric, n = 3. Wild type or S317/555/777A mutational cardiomyocytes were treated with PEDF or Go6976 under normal conditions or before OGD 4 hours. *P < 0.05, **P < 0.01 vs normal control, # P < 0.05, ## P < 0.01 vs OGD control, Δ P < 0.05, ΔΔ P < 0.01 vs OGD+PEDF group
